Quarantined Human Plasma Pool from Japan
Pooled human plasma held in quarantine pending complete viral testing before release for fractionation. Therapeutic source material. HTS 3002.12.00.10 applies to plasma prepared for therapeutic uses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include quarantine release letter from fractionator confirming negative NAT panel
• Declare intended end-use fractionation (e.g
• FVIII, albumin) in entry summary